| ASSET | YEAR | % RETURN |
|---|---|---|
Teva Pharma Industries Ltd ADR (TEVA) | 2010 | -7.41% |
Teva Pharma Industries Ltd ADR (TEVA) | 2011 | -21.72% |
Teva Pharma Industries Ltd ADR (TEVA) | 2012 | -9.11% |
Teva Pharma Industries Ltd ADR (TEVA) | 2013 | 9.56% |
Teva Pharma Industries Ltd ADR (TEVA) | 2014 | 47.58% |
Teva Pharma Industries Ltd ADR (TEVA) | 2015 | 17.29% |
Teva Pharma Industries Ltd ADR (TEVA) | 2016 | -42.1% |
Teva Pharma Industries Ltd ADR (TEVA) | 2017 | -46.6% |
Teva Pharma Industries Ltd ADR (TEVA) | 2018 | -17.8% |
Teva Pharma Industries Ltd ADR (TEVA) | 2019 | -35.7% |
Teva Pharma Industries Ltd ADR (TEVA) | 2020 | -2.23% |
Teva Pharma Industries Ltd ADR (TEVA) | 2021 | -17.51% |
Teva Pharma Industries Ltd ADR (TEVA) | 2022 | 13.29% |
Teva Pharma Industries Ltd ADR (TEVA) | 2023 | 13.73% |
Teva Pharma Industries Ltd ADR (TEVA) | 2024 | 110.51% |
Teva Pharma Industries Ltd ADR (TEVA) | 2025 | 41.67% |
Teva Pharma Industries Ltd ADR (TEVA) | 2026 | 30.6% |